共 139 条
[1]
Dasari A(2017)Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States JAMA Oncol 3 1335-1342
[2]
Shen C(2020)Gastroenteropancreatic neuroendocrine neoplasms: ESMO clinical practice guidelines for diagnosis, treatment and follow-up Ann Oncol 31 844-860
[3]
Halperin D(2012)ENETS consensus guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes Neuroendocrinology 95 98-119
[4]
Zhao B(2021)Perspectives on the current pharmacotherapeutic strategies for management of functional neuroendocrine tumor syndromes Expert Opin Pharmacother 22 685-693
[5]
Zhou S(2012)Neuroendocrine pancreatic tumors: guidelines for management and update Curr Treat Options Oncol 13 24-34
[6]
Xu Y(2017)Stage IV gastro-entero-pancreatic neuroendocrine neoplasms: a risk score to predict clinical outcome Oncologist 22 409-415
[7]
Shih T(2020)The functioning side of the pancreas: a review on insulinomas J Endocrinol Invest 43 139-148
[8]
Yao JC(2016)ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors Neuroendocrinology 103 153-171
[9]
Pavel M(2021)Gastrinoma and Zollinger Ellison syndrome: a roadmap for the management between new and old therapies World J Gastroenterol 27 5890-5907
[10]
Öberg K(2019)Multidisciplinary management of neuroendocrine neoplasia: a real-world experience from a referral center J Clin Med 8 910-374